Yi Zhang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

African American

Prognostic Factors

Mycobacterium Tuberculosis

Top Venues

Journal of proteome research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Correction for Zhang et al., "Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections". mBio (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Liang V Tang, Yanyi Tao, Yuanzheng Feng, Jiewen Ma, Wenyi Lin, Yuyang Zhang, Yi Zhang, Tingting Wu, Yaohua Cai, Hui Lu, Jun Wei, Javier Corral, Han Yan
Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Science translational medicine 14 (673) (2022)
Yi Zhang, Liang V Tang
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication. Journal of proteome research 20 (1) (2020)